Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Clinical Research in Cardiology
Literature
1.
Cooper LT Jr, Berry GJ, Shabetai R (1997) Idiopathic giant-cell myocarditis–natural history and treatment. Multicenter Giant Cell Myocarditis Study Group Investigators. N Engl J Med 336:1860–1866PubMedCrossRef
2.
Di Bella G, Florian A, Oreto L, Napolitano C, Todaro MC, Donato R, Calamelli S, Camastra GS, Zito C, Carerj S, Bogaert J, Oreto G (2012) Electrocardiographic findings and myocardial damage in acute myocarditis detected by cardiac magnetic resonance. Clin Res Cardiol 101:617–624PubMedCrossRef
3.
Frustaci A, Chimenti C, Pieroni M, Gentiloni N (2000) Giant cell myocarditis responding to immunosuppressive therapy. Chest 117:905–907PubMedCrossRef
4.
Cooper LT Jr, Hare JM, Tazelaar HD, Edwards WD, Starling RC, Deng MC et al (2008) Usefulness of immunosuppression for giant cell myocarditis. Am J Cardiol 102:1535–1539PubMedCentralPubMedCrossRef
5.
Caforio AL, Calabrese F, Angelini A, Tona F, Vinci A, Bottaro S et al (2007) A prospective study of biopsy-proven myocarditis: prognostic relevance of clinical and aetiopathogenetic features at diagnosis. Eur Heart J 28:1326–1333PubMedCrossRef
6.
Escher F, Westermann D, Gaub R, Pronk J, Bock T, Al-Saadi N et al (2011) Development of diastolic heart failure in a 6-year follow-up study in patients after acute myocarditis. Heart 97:709–714PubMedCrossRef
7.
Piggott K, Biousse V, Newman NJ, Goronzy JJ, Weyand CM (2009) Vascular damage in giant cell arteritis. Autoimmunity 42:596–604PubMedCrossRef
8.
Deng J, Ma-Krupa W, Gewirtz AT, Younge BR, Goronzy JJ, Weyand CM (2009) Toll-like receptors 4 and 5 induce distinct types of vasculitis. Circ Res 104:488–495PubMedCentralPubMedCrossRef
9.
Alvarez Rodriguez L, Lopez-Hoyos M, Mata C, Fontalba A, Calvo Alen J, Marin MJ et al (2011) Expression and function of toll-like receptors in peripheral blood mononuclear cells of patients with polymyalgia rheumatica and giant cell arteritis. Ann Rheum Dis 70:1677–1683PubMedCrossRef
10.
Pryshchep O, Ma-Krupa W, Younge BR, Goronzy JJ, Weyand CM (2008) Vessel-specific toll-like receptor profiles in human medium and large arteries. Circulation 118:1276–1284PubMedCentralPubMedCrossRef
11.
Reinhard W, Kallmuenzer B, Bergua A, Fleck M, Luchner A, Riegger G, Fredersdorf S (2011) Reversible complete heart block in ANCA-associated vasculitis. Clin Res Cardiol 100:93–95PubMedCrossRef
Metadata
Title
Vascular involvement in cardiac giant cell myocarditis: a new pathophysiological aspect
Authors
S. Elezkurtaj
D. Lassner
H.-P. Schultheiss
F. Escher
Publication date
01-02-2014
Publisher
Springer Berlin Heidelberg
Published in
Clinical Research in Cardiology / Issue 2/2014
Print ISSN: 1861-0684
Electronic ISSN: 1861-0692
DOI
https://doi.org/10.1007/s00392-013-0638-2

Other articles of this Issue 2/2014

Clinical Research in Cardiology 2/2014 Go to the issue

Original Paper

Heart rate is associated with increased risk of major cardiovascular events, cardiovascular and all-cause death in patients with stable chronic cardiovascular disease: an analysis of ONTARGET/TRANSCEND

Original Paper

Renal sympathetic denervation therapy in the real world: results from the Heidelberg registry

Original Paper

Can postoperative mean transprosthetic pressure gradient predict survival after aortic valve replacement?

Original Paper

Short-term outcome of patients with ST-segment elevation myocardial infarction (STEMI) treated with an everolimus-eluting bioresorbable vascular scaffold

Original Paper

Connective tissue growth factor (CTGF/CCN2): diagnostic and prognostic value in acute heart failure

Letter to the Editors

Transcatheter creation of a de novo communication across an extracardiac Fontan conduit for catheter ablation of a “left-sided” accessory pathway

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits